Hybrid aminoglycoside antibiotics via tsuji palladium-catalyzed allylic deoxygenation

Organic Letters

Volumn 13, Issue 24, 2011, Pages 6476-6479

  Hanessian, Stephen ^a   Maianti, Juan Pablo ^a   Matias, Rowena D ^b   Feeney, Lee Ann ^b   Armstrong, Eliana S ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Achaogen Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; NEOMYCIN; PALLADIUM; PAROMOMYCIN; SISOMICIN;

ARTICLE; CATALYSIS; CHEMISTRY; OXIDATION REDUCTION REACTION; SYNTHESIS;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; CATALYSIS; NEOMYCIN; OXIDATION-REDUCTION; PALLADIUM; PAROMOMYCIN; SISOMICIN;

EID: 84055213972     PISSN: 15237060     EISSN: 15237052     Source Type: Journal    
DOI: 10.1021/ol2027703     Document Type: Article

References (32)

1. (a) Arya, D. P. Aminoglycoside Antibiotics: From Chemical Biology to Drug Discovery; Wiley: Hoboken, NJ, 2007.
2. (b) Walsh, C Antibiotics: Actions, Origins, Resistance; ASM Press: Washington, DC, 2003.
3. (a) Ogle, J. M.; Ramakrishnan, V. Annu. Rev. Biochem. 2005, 74, 129.
4. (b) Franc-ois, B.; Russell, R. J.; Murray, J. B.; Abouléla, F.; Masquida, B.; Vicens, Q.; Westhof, E. Nucleic Acids Res. 2005, 33, 5677.
5. (a) Magnet, S.; Blanchard, J. S. Chem. Rev. 2005, 105, 477.
6. (b) Shaw, K. J.; Rather, P. N.; Hare, R. S.; Miller, G. H Microbiol. Rev. 1993, 57, 138.
7. (c) Vakulenko, S. B.; Mobashery, S. Clin. Microbiol. Rev. 2003, 16, 430.
8. (d) Smith, C. A.; Baker, E. N. Curr. Drug Targets Infect. Disord. 2002, 2, 143.
9. (e) Davies, J. Science 1994, 264, 375.
10. (a) Mingeot-Leclercq, M. P.; Glupczynski, Y.; Tulkens, P. M. Antimicrob. Agents Chemother. 1999, 43, 727.
11. (b) Li, J.; Chang, C.-W. T. Anti-Infective Agents Med Chem 2006, 5, 255.
12. For review of medicinal chemistry efforts 1975-85, see: Price, K. E. Am. J. Med. 1986, 80, 182.
13. Davidson, R. N.; den Boer, M.; Ritmeijer, K. Trans. R. Soc. Trop. Med. Hyg. 2009, 103, 653.
14. See Supporting Information for further details, complete listing of aminoglycosides, and a proposed biosynthetic pathway.
15. For review of aminoglycoside biosynthesis, see ref 1a and
16. Flatt, P. M.; Mahmud, T. Nat Prod Rep. 2007, 24, 358.
17. (b) Llewellyn, N. M.; Spencer, J. B. Nat. Prod. Rep. 2006, 23, 864.
18. Testa, R. T.; Tilley, B. C. Jpn. J. Antibiot. 1979, 32, S47.
19. (a) Franc-ois, B.; Szychowski, J.; Adhikari, S. S.; Pachamuthu, K.; Swayze, E. E.; Griffey, R. H.; Migawa, M. T.; Westhof, E.; Hanessian, S. Angew. Chem., Int. Ed. Engl. 2004, 43, 6735.
20. (b)Hanessian, S.; Pachamuthu, K.; Szychowski, J.;Giguére,A.; Swayze, E. E.; Migawa, M. T.; Franc-ois, B.; Kondo, J.; Westhof, E. Bioorg. Med. Chem. Lett. 2010, 23, 7097 and references within.
21. (a) Dairi, T.; Ohta, T.; Hashimoto, E.; Hasegawa, M. Mol. Gen. Genet. 1992, 236, 39.
22. (b) Unwin, J.; Standage, S.; Alexander, D.; Hosted, T., Jr.; Horan, A. C.; Wellington, E. M. J. Antibiot.(Tokyo) 2004 57 436.
23. (c) Hong,W. R.; Ge, M.; Zeng, Z. H.; Zhu, L.; Luo, M. Y.; Shao, L.; Chen, D. J. Biotechnol. Lett. 2009, 31, 449.
24. For review, see: Tsuji, J.; Mandai, T. Synthesis 1996, 1, 1.
25. For applications to natural product synthesis, see: Wipf P. Methot J. L. Org. Lett. 2000 2 4213.
26. (b) Wipf, P.; Rector, S. R.; Takahashi, H. J. Am. Chem. Soc. 2002, 124, 14848.
27. (c) Wipf, P.; Spencer, S. R. J. Am. Chem. Soc. 2005, 127, 225.
28. For an application of a similar reaction to carbohydrates, see: Greenspoon, N.; Keinan, E. J. Org. Chem. 1988, 53, 3723.
29. (a) Hanessian, S.; Takamoto, T.; Masse, R.; Patil, G. Can. J. Chem. 1978, 56, 1482.
30. (b) Pathak, R.; Böttger, E. C.; Vasella, A. Helv. Chim. Acta 2005, 88, 2967.
31. (a) Paulsen, H.; Jansen, R. Carbohydr. Res. 1981, 92, 305.
32. (b) Girodeau, J. M.; Pineau, R.; Masson, M.; Le Goffic, F. J. Antibiot. (Tokyo) 1984, 37, 150.